New eye injection shows promise for common vision loss conditions
Disease control
Completed
This early-stage study tested the safety of two different versions of an experimental eye injection called OLN324. The trial involved 164 adults with either wet age-related macular degeneration or diabetic macular edema, two conditions that can cause vision loss. Researchers want…
Phase: PHASE1 • Sponsor: Ollin Biosciences, Inc. • Aim: Disease control
Last updated Apr 02, 2026 07:26 UTC